Honored and grateful to receive the 2026 Outstanding Achievement in Patient Care Award @utswcancer@UTSWMedCenter.
This award means so much because it recognizes what first drew me to oncology: caring for patients with compassion and purpose.
#MedTwitter#HemeOnc#UTSW
Thrilled and honored to be selected for the 2026 AACR/ASCO Methods in Clinical Cancer Research Workshop in Vail! This is especially meaningful as a 1st-year fellow @utswcancer . Excited to develop my #clinicaltrial protocol with @AACR / @ASCO faculty! #AACR#ASCO
Sharing our latest article with @MuhammetOzerMD out in @JCOOP_ASCO “Repurposing Renin-Angiotensin System Inhibitors in Colon Cancer: Signal, Plausibility, and the Need for Prospective Validation”, discussing drug repurposing in oncology @TheGutOncLab
https://t.co/LCbprhiEUW
Presenting at #GI26@ASCO. Honored to receive a @ConquerCancerFd Merit Award🎖️. Phase II study of ATRA + atezolizumab + bevacizumab in refractory MSS #mCRC. Manageable, mostly low-grade #AEs. Efficacy data forthcoming🎢 | Great mentorship from @SyedKazmiMD@utswcancer